Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1621 1629 1684
This examiner grants 57% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17786764 | INHIBITORS OF LIN28 AND METHODS OF USE THEREOF | Non-Final OA | The Regents of the University of California |
| 18063048 | BINDING SITE IN TYPE 2 RYANODINE RECEPTOR | Non-Final OA | The Trustees of Columbia University in the City of New York |
| 18557899 | STABLE ISOQUINOLINE-CORTICOSTEROID CONJUGATES AND USES THEREOF | Non-Final OA | ALCON INC. |
| 18041475 | METHOD OF PRODUCING PHARMACEUTICAL COCRYSTALS FOR ADDITIVE MANUFACTURING | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18134971 | TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED PROTEINS | Non-Final OA | C4 Therapeutics, Inc. |
| 17764092 | FUSED PYRIMIDINE COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF | Final Rejection | LENGO THERAPEUTICS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy